| Literature DB >> 35799927 |
Amol V Pansare1,2, Priyanka V Pansare3, Amol A Shedge2, Shubham V Pansare2, Vishwanath R Patil2, Giovanni P Terrasi1, Kamini J Donde3.
Abstract
We developed a cost-effective and eco-friendly click biosynthesis of small molecule quercetin-gold quantum dots (QRT-AuQDs) involving quick conjugation using an ultrasonication method at ambient temperature by utilizing QRT and gold ions in the proportion of 0.1 : 1 (molar ratio). A comparatively very short amount of time (60 seconds) was required as compared to conventional procedures. The present biomimetics research relates to the isolation of bioactive QRT by the circularly spread silica gel layer technique (CSSGLT) and characterization (UV-Vis, FTIR, NMR and DSC analysis). Characterization of the synthesized QRT-AuQDs conjugated complex was carried out by UV-Vis, HR-TEM, DLS, zeta potential and X-ray diffraction. The main objective of the present work was to study the comparative anticancer activity of QRT and QRT-AuQDs on human lung cancer HOP-62 and leukemia K-562 cell lines. The results suggested that QRT-AuQDs showed potential for applications in anticancer treatment and were found to be a more cytotoxic agent in comparison to QRT, causing > 50% inhibition of cancer cells at the concentration < 10-7 M. Hence, small molecule conjugated QRT-AuQDs can be used as a promising material for biomedical, bioengineering and anti-infectives applications. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35799927 PMCID: PMC9218964 DOI: 10.1039/d2ra02529a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Structural formula for quercetin isolated from F. Arnottiana.
Fig. 2UV-vis absorption spectra of QRT, HAuCl4 and QRT–AuQDs.
Fig. 3X-ray diffractograms of QRT and QRT–AuQDs.
Fig. 4HR-TEM images of QRT–AuQDs.
Fig. 5% Control growth curve of human lung cancer cell line HOP-62 with QRT, QRT–AuQDs and ADR positive control compound in molar concentrations.
Fig. 6% Control growth curve of human leukemia cancer cell line K-562 with QRT, QRT–AuQDs and adriamycin (ADR) positive control compound in molar concentrations.
HOP-62 human lung cancer cell line activity of QRT and QRT–AuQDsa
| Drug concentrations (μmolar) calculated from graph | |||
|---|---|---|---|
| HOP-62 | LC50 | TGI | GI50* |
| QRT | >100 | 50.43 | <0.1 |
| QRT–AuQDs | >100 | 40.47 | <0.1 |
| ADR | <0.1 | 15.2 | <0.1 |
LC50 = concentration of drug causing 50% cell death, GI50 = concentration of drug causing 50% inhibition of cell growth, TG = concentration of drug causing total inhibition of cell growth, ADR = adriamycin, the positive control compound, a GI50 value of ≤10−6 molar (i.e. 1 μmolar) is considered to demonstrate activity.[50–52]
K-562 human leukemia cell line activity of QRT and QRT–AuQDs
| Drug concentrations (μmolar) calculated from graph | |||
|---|---|---|---|
| K-562 | LC50 | TGI | GI50* |
| QRT | >100 | >100 | 7.22 |
| QRT–AuQDs | >100 | <0.1 | <0.1 |
| ADR | >100 | >100 | <0.1 |